CLINICAL_TRIALS
trial_result
· 2014-06-12
Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012) [Phase 1]
Summary
Phase 1 pharmacokinetic and pharmacodynamic study of MK-8245 in participants with type 2 diabetes completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2014-06-12